Xtant Medical Holdings Inc Total Assets
Xtant Medical Holdings Inc total assets. Based on the latest financial reports, Xtant Medical Holdings Inc (XTNT) holds total assets worth $94.14 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is Xtant Medical Holdings Inc worth for the company's overall valuation and market capitalisation.
Total Assets of Xtant Medical Holdings Inc (2008–2025)
Total assets of Xtant Medical Holdings Inc from 2008 to 2025. This chart illustrates how Xtant Medical Holdings Inc's total assets have evolved over time, based on quarterly financial data. See Xtant Medical Holdings Inc (XTNT) share price today for real-time trading data and today's change.
Xtant Medical Holdings Inc - Asset Composition Analysis
Xtant Medical Holdings Inc Total Assets Breakdown (December 2025)
Xtant Medical Holdings Inc total assets breakdown as of December 2025. Xtant Medical Holdings Inc's total assets of $94.14 Million consist of 83.1% current assets and 16.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 18.1% |
| Accounts Receivable | $17.80 Million | 18.9% |
| Inventory | $30.26 Million | 32.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $299.00K | 0.3% |
| Goodwill | $6.07 Million | 6.5% |
Asset Composition Trend (2008–2025)
This chart illustrates how Xtant Medical Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore XTNT working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Xtant Medical Holdings Inc's current assets represent 83.1% of total assets in 2025, a decrease from 100.0% in 2008.
- Cash Position: Cash and equivalents constituted 18.1% of total assets in 2025, down from 31.3% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 0.0% in 2008.
- Asset Diversification: The largest asset category is inventory at 32.2% of total assets.
Xtant Medical Holdings Inc Competitors by Total Assets
Key competitors of Xtant Medical Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
GN Store Nord
CO:GN
|
Denmark | Dkr29.23 Billion |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
|
China | CN¥1.86 Billion |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
VIROMED MEDICAL NA O.N.
XETRA:VME
|
Germany | €13.91 Million |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Xtant Medical Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.65 | 2.35 | 2.02 |
| Quick Ratio | 1.63 | 1.00 | 1.12 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $48.76 Million | $38.53 Million | $24.47 Million |
Xtant Medical Holdings Inc - Advanced Valuation Insights
This section examines the relationship between Xtant Medical Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.43 |
| Latest Market Cap to Assets Ratio | 0.71 |
| Asset Growth Rate (YoY) | 0.3% |
| Total Assets | $94.14 Million |
| Market Capitalization | $67.23 Million USD |
Valuation Analysis
Below Book Valuation: The market values Xtant Medical Holdings Inc's assets below their book value (0.71x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Xtant Medical Holdings Inc's assets grew by 0.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Xtant Medical Holdings Inc (2008–2025)
The table below shows the annual total assets of Xtant Medical Holdings Inc from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $94.14 Million | +0.33% |
| 2024-12-31 | $93.84 Million | +1.32% |
| 2023-12-31 | $92.61 Million | +53.77% |
| 2022-12-31 | $60.23 Million | +10.12% |
| 2021-12-31 | $54.69 Million | +31.90% |
| 2020-12-31 | $41.47 Million | -3.91% |
| 2019-12-31 | $43.16 Million | -7.04% |
| 2018-12-31 | $46.42 Million | -56.08% |
| 2017-12-31 | $105.70 Million | -26.65% |
| 2016-12-31 | $144.10 Million | +0.73% |
| 2015-12-31 | $143.06 Million | +411.82% |
| 2014-12-31 | $27.95 Million | -3.21% |
| 2013-12-31 | $28.88 Million | -16.29% |
| 2012-12-31 | $34.50 Million | +48.88% |
| 2011-12-31 | $23.17 Million | +46.98% |
| 2010-12-31 | $15.76 Million | +50.33% |
| 2009-12-31 | $10.49 Million | +7404.61% |
| 2008-12-31 | $139.73K | -- |
About Xtant Medical Holdings Inc
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validate… Read more